Cardiac involvement in systemic rheumatic diseases: An update

Autoimmunity Reviews

Volumn 9, Issue 12, 2010, Pages 849-852

  Sarzi Puttini, Piercarlo ^a   Atzeni, Fabiola ^a   Gerli, Roberto ^b   Bartoloni, Elena ^b   Doria, Andrea ^c   Barskova, Tatiana ^d   Matucci Cerinic, Marco ^d   Sitia, Simona ^e   Tomasoni, Livio ^e   Turiel, Maurizio ^e  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Atherosclerosis; Autoimmune diseases; Heart; Rheumatoid arthritis; Systemic lupus erythematosus; Systemic sclerosis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ATHEROGENESIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; EARLY MENOPAUSE; ENDOCARDIUM; EPICARDIUM; HEART MUSCLE; HUMAN; IMMUNE DYSREGULATION; INFLAMMATORY DISEASE; MORBIDITY; MORTALITY; PERICARDIUM; PROGNOSIS; REVIEW; RHEUMATIC DISEASE; RISK FACTOR; SIDE EFFECT; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VALVULAR HEART DISEASE;

ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; EARLY DIAGNOSIS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 77956917813     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.08.002     Document Type: Review

References (40)

1. Turiel M., Sitia S., Atzeni F., Tomasoni L., Gianturco L., Giuffrida M., et al. The heart in rheumatoid arthritis. Autoimmun Rev 2010, 9:414-418.
2. Sitia S., Atzeni F., Sarzi-Puttini P., Di Bello V., Tomasoni L., Delfino L., et al. Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 2009, 8:281-286.
3. Del Rincon I., Williams K., Stern M.P., Freeman G.L., Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 44:2737-2745.
4. Nurmohamed M.T. Cardiovascular risk in rheumatoid arthritis. Autoimmun Rev 2009, 8:663-667.
5. Shoenfeld Y., Gerli R., Doria A., Matsuura E., Cerinic M.M., Ronda N., et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005, 112:3337-3347.
6. Montecucco F., Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology 2009, 48:11-22.
7. Bartoloni E., Alunno A., Bistoni O., Gerli R. How early is the atherosclerotic risk in rheumatoid arthritis?. Autoimmun Rev 2010, 9:701-707.
8. Gerli R., Sherer Y., Bocci E.B., Vaudo G., Moscatelli S., Shoenfeld Y. Precocious atherosclerosis in rheumatoid arthritis. Role of traditional and disease-related cardiovascular risk factors. Ann NY Acad Sci 2007, 1108:372-381.
9. Bang S.Y., Lee K.H., Cho S.K., Lee H.S., Lee K.W., Bae S.C. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheum 2010, 62:369-377.
10. Gerli R., Bartoloni Bocci E., Sherer Y., Vaudo G., Moscatelli S., Shoenfeld Y. Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 2008, 67:724-725.
11. - T cells: their role in the age-associated decline of immune function. Trends Immunol 2009, 30:306-312.
12. - T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004, 109:2744-2748.
13. Tyrrell P.N., Beyene J., Feldman B.M., McCrindle B.W., Silverman E.D., Bradley T.J. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2010, 30:1014-1026.
14. null cells in the acceleration of atherosclerosis in rheumatoid. Arthritis Rheum 2009, 60:631-632.
15. Gerli R., Vaudo G., Bocci E.B., Schillaci G., Alunno A., Luccioli F., Hijazi R., Mannarino E., Shoenfeld Y. Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors. Arthritis Care Res (Hoboken) 2010, 62:712-718.
16. Kokkonen H., Söderström I., Rocklöv J., Hallmans G., Lejon K., Rantapää Dahlqvist S. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 2010, 62:383-391.
17. Doria A., Iaccarino L., Sarzi-Puttini P., Atzeni F., Turriel M., Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005, 14:683-686.
18. Colombo B.M., Cacciapaglia F., Puntoni M., Murdaca G., Rossi E., Rodriguez G., et al. Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). Autoimmun Rev 2009, 8:309-315.
19. Doria A., Iaccarino L., Ghirardello A., Zampieri S., Arienti S., Sarzi-Puttini P., et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006, 119:1497-1499.
20. Turiel M., Peretti R., Sarzi-Puttini P., Atzeni F., Doria A. Cardiac imaging techniques in systemic autoimmune diseases. Lupus 2005, 14:727-731.
21. Doria A. Atherosclerosis and lupus: what we know and what we should know. J Rheumatol 2009, 36:2380-2382.
22. Bizzarro N., Ghirardello A., Zampieri S., Iaccarino L., Tozzoli R., Ruffatti A., et al. Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study. J Thromb Haemost 2007, 5:1158-1164.
23. Doria A., Sherer Y., Meroni P.L., Shoenfeld Y. Inflammation and accelerated atherosclerosis - basic mechanisms. Rheum Dis Clin N Am 2005, 31:329-354.
24. Bassi N., Zampieri S., Ghirardello A., Tonon M., Zen M., Cozzi F., et al. Pentraxins, anti-pentraxin antibodies, and atherosclerosis. Clin Rev Allergy Immunol 2009, 37:36-43.
25. Doria A., Shoenfeld Y., Pauletto P. Premature coronary disease in systemic lupus. N Eng J Med 2004, 350:1571-1575.
26. Doria A., Shoenfeld Y., Wu R., Gambari P.F., Puato M., Ghirardello A., et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003, 62:1071-1077.
27. Doria A., Briani C. Primary prevention of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2008, 4:576-577.
28. Doria A., Arienti S., Rampudda M., Canova M., Tonon M., Sarzi-Puttini P. Preventive strategies in systemic lupus erythematosus. Autoimmun Rev 2008, 7:192-197.
29. Doria A., Briani C. Lupus: improving long-term prognosis. Lupus 2008, 17:166-170.
30. Guiducci S., Giacomelli R., Matucci Cerinic M. Vascular complications of scleroderma. Autoimmune Rev 2007, 6:520-523.
31. Kahan A., Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology 2006, 45:14-17.
32. Kaloudi O., Matucci Cerinic M. Systemic sclerosis: the heart puzzle. Rheumatologist 2009, 3:13-15.
33. Anvari A., Granger W., Schneder B., Sochor H., Weber H., Schmidinger H. Cardiac involvement in systemic sclerosis. Arthritis Rheum 1992, 35:1356-1361.
34. De Subitaneis Mortibus James T.N. Coronary arteries and conduction system in scleroderma heart disease. Circulation 1974, 50:844-856.
35. Bukley B.H., Ridolfi R.L., Salyer W.R., Hutchins G.M. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976, 53:483-490.
36. Kostis J.B., Seibold J.R., Turkevich D., Masi A.T., Grau R.G., Medsger T.A., et al. Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med 1988, 84:1007-1015.
37. Martinez-Taboada V., Olalla J., Blanco R., Armona J., Sueiro J.F., Rodriguez-Valverde V. Malignant ventricular arrhythmia in systemic sclerosis controlled with an implantable cardioverter defibrillator. J Rheumatol 1994, 21:2166-2167.
38. Long A., Duffy G., Bresnihan B. Reversible myocardial perfusion defects during cold challenge in scleroderma. Br J Rheumatol 1986, 25:158-161.
39. Follansbee W.P., Zerbe T.R. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma):a high risk association. Am Heart J 1993, 125:194-203.
40. Bernardo P., Conforti M.L., Bellando-Randone S., Pieragnoli P., Blagojevic J., Kaloudi O., et al Implantable cardioverter defibrillator prevent sudden cardiac death in Systemic Sclerosis. Submitted.